The approval of the EPA's Science Advisory Board is conditioned on minor clarifications being made to a draft report submitted by a review panel, but no major changes will be made to the panel's findings.
The revisions called for by the SAB include making a cover letter to EPA Administrator Stephen Johnson more reader-friendly and clarifying the scope of dissent among members of the SAB panel that reviewed the EPA's draft risk assessment of perfluorooctanoic acid, also known as C-8.
Board members also agreed that the report should clarify why some unpublished scientific studies were considered by the panel while others weren't, and that the panel's findings should not be considered the last word on PFOA but should be updated as additional data become available.
PFOA is a processing aid used in the manufacturing of fluoropolymers, which have a wide variety of product applications, including nonstick cookware.
The chemical also can be a byproduct in the manufacturing of fluorotelomers used in surface protection products for applications such as stain-resistant textiles and grease-resistant food wrapping.
Wilmington, Del.-based DuPont Co., owner of the Teflon brand, is the sole producer of PFOA in North America.
Some members of the review panel disagreed with the majority view that PFOA should be classified as a "likely carcinogen," a finding that went beyond the EPA's own determination that there was only "suggestive evidence" from animal studies that PFOA and its salts are potential human carcinogens.
"Are we talking two-fifths of the panel, or are we talking about a small number?" asked SAB Chairman M. Granger Morgan, head of the department of engineering and public policy at Carnegie Mellon University.
Deborah Cory-Slechta, chair of the PFOA risk assessment review panel, said dissent from the majority views of the 16-member panel on issues it was asked to study typically was limited to three or four members.